Font Size: a A A

The Clinical Research Of Contrast-induced Nephropathy After Primary Percutaneous Coronary Intervention In Patients With Acute Coronary Syndrome

Posted on:2011-07-07Degree:MasterType:Thesis
Country:ChinaCandidate:Y X MiaoFull Text:PDF
GTID:2154360308965697Subject:Department of Cardiology
Abstract/Summary:PDF Full Text Request
Objective:To observer alterations of baseline renal functional in patients with acute coronary syndrome (ACS) and its clinic adverse events after percutaneous coronary intervention(PCI),and to explore the related factors of contrast-indeced nephropathy (CIN) and their effects on the prognosis of patients. Methods:the data on 78 patients with ACS who received PCI form October 2006 to October 2009 and material integrity were enrolled to observed patients baseline renal function and their alteration 48-72 hours before and after PCI. And clinic adverse events 6-24 months after PCI. to analyzes the related factors of contrast-indeced nephropathy and their effects of its adverse events. Results:five patients(6.4%) had rendal dysfunction before PCI using Scr as the detective index., whereas (46.1%) Demonstrated renal dysfunction using Ccr as the index.Renal function deteriorated in patients(14%) after PCI. Resulting in contrast-induced nephropathy (CIN),4 of them Had normal baseline renal function and 10 were abnormal in Baseline renal function. The incidence of CIN was hinger in those with chronic kidney diease or heart failure, old age,diabetes mellitus (Dm), receiving high dose of contrast media or urgent PCI. Average hospital stay was longer, and the incidences of clinic adverse events and overall mortality were hinger in CIN group than in non-CIN group (P<0.05). Conclusion:Abnormal baseline renalfunction or chronic kidney disease, heart failure, old age, use of high dose of contrast media, Dm, and urgent PCI are the relatd factors for deveioping CIN after PCI, CIN can significantly prolong length of hospital stay, incease the incidences of Adverse events and mortality.
Keywords/Search Tags:Acute coronary syndrome, Percutaneous coronary intervention, Contrast-induced nephropathy, The affecting factor
PDF Full Text Request
Related items
The Drug Interventional Study Of Contrast-induced Nephropathy In Patients With Acute Coronary Syndrome Undergoing Elective Coronary Angiography Or Percutaneous Coronary Intervention
Risk Factor Analysis For Contrast-induced Nephropathy In Patients Of Acute Coronary Syndrome With Normal Or Slightly Impaired Renal Function After Percutaneous Coronary Intervention
A Study Of The Variation Of Renal Function In Acute Coronary Syndrome Undergoing Coronary Intervention And Contrast Induced Nephropathy(CIN) Related Risk Factors
Correlation Study Of Contrast-induced Nephropathy After Percutaneous Coronary Intervention For Coronary Heart Disease
Effects Of Nicorandil On Contrast-Induced Nephropathy In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Analysis Of Risk Factors And Prevention Of Contrast-induced Nephropathy In Patients Undergoing Coronary Angiography Or Percutaneous Coronary Intervention
Efficacy Of Alprostadil In Preventing Contrast Induced Nephropathy In Elderly Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
The Preventive Efficacy Of Salvianolate On Contrast-induced Nephropathy After Emergency Percutaneous Coronary Intervention:A Clinical Trail
Clinical Study Of Contrast-induced Nephropathy In Patients Undergoing Coronary Intervention
10 Intensive Atorvastatin Therapy To Prevent Contrast-induced Nephropathy In Patient With Acute St-segment Elevation Myocardial Infarction Undergoing Emergency Percutaneous Coronary Invention